Skip to main content
PRIMR23 SBER23 Main banner
Icon Legend
Presentation Icons
Pre-Reg Required
Pre-Reg Required
Additional Fee
Additional Fee
Livestreaming Session Icon
Livestreaming Session Icon
Live Session Recorded
Live Session Recorded
On-Demand Session
On-Demand Session
CIP Accredited
CIP Accredited
CPIA Accredited
CPIA Accredited
Call for Session Proposal
Call for Session Proposal
Human Subjects Research
Human Subjects Research
IACUC/Animal Care and Use
IACUC/Animal Care and Use
Crossover
Crossover
Institutional Leadership
Institutional Leadership
Workshop Series
Workshop Series
Thought Leader Series
Thought Leader Series
Deep Dive Series
Deep Dive Series
Learning Lab Series
Learning Lab Series
Networking Series
Networking Series
Vendor Insight Series
Vendor Insight Series
Pillars of PRIM&R Poster Award
Pillars of PRIM&R Poster Award
Poster Icons
Record Session Icon
Record Session Icon
Pre-Reg Required
Pre-Reg Required
Part I/II
Part I/II
CSP Icon
CSP Icon
Livestreaming Session Icon
Livestreaming Session Icon
Prerecorded Session Icon
Prerecorded Session Icon
CIP Accredited
CIP Accredited
Pillars Icon
Pillars Icon
Back
View Video

2023 PRIM&R Annual Conference

Pharma/Biotech Perspectives

Advancing Equity and Justice in Research

H04 - [IN-PERSON/RECORDED] Eliminating Financial Barriers to Clinical Study Participation: The Need for Industry and Academic Partnership for a Sustainable Solution

Wednesday, December 6, 2023
1:45 PM – 2:45 PM ET
Location: Room 144 AB
Human Subjects Research Call for Session Proposal Live Session Recorded Deep Dive Series
This session will be offered in-person and recorded for on-demand access by in-person PRIMR23 attendees registered for this day, and PRIMR23/SBER23 Virtual Meeting registrants.

To advance health equity and further promote diversity and inclusion in clinical research, industry and academia need to work together to overcome many challenges. A particularly vexing issue is potential out-of-pocket costs to study participants in interventional clinical research studies who may be un- or under insured (e.g., co-pays, tests/procedures associated with standard of care). Eliminating this barrier while ensuring that ethical and regulatory imperatives are abided is complicated. This session will identify challenges and issues associated with full cost neutrality to study participants in interventional clinical research studies and explore potential solutions to resolve them ethically and compliantly.

Learning Objectives:

  • Review the different ways in which financial considerations serve as barriers to participation which hamper efforts to ensure equitable subject selection
  • Explore how decisions regarding site selection, eligibility requirements, and compensation and reimbursement considerations affect who can participate in clinical trials
  • Discuss innovative approaches that have been implemented in clinical trials to achieve cost neutrality for participants